Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma

Hyaluronan Induces Cell Death in Activated T Cells through CD44

(2014) B. Ruffell et al.   JOURNAL OF IMMUNOLOGY

Altered Hyaluronan Biosynthesis and Cancer Progression: an Immunological Perspective

(2010) Laura Alaniz et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Human myeloid dendritic cells for cancer therapy: Does maturation matter?

(2010) Katerina Skalova et al.   VACCINE

Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response

(2009) Laura Alaniz et al.   CANCER LETTERS

A Novel Synergistic Combination of Cyclophosphamide and Gene Transfer of Interleukin-12 Eradicates Colorectal Carcinoma in Mice

(2009) M. Malvicini et al.   CLINICAL CANCER RESEARCH

Dendritic Cell Maturation With Poly(I:C)-based Versus PGE2-based Cytokine Combinations Results in Differential Functional Characteristics Relevant to Clinical Application

(2009) Ines Möller et al.   JOURNAL OF IMMUNOTHERAPY

Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells

(2009) Paul L. Bollyky et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Dendritic cell-based cancer vaccination:quo vadis?

(2008) M Dauer et al.   Expert Review of Vaccines

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma

(2008) Daniel H. Palmer et al.   HEPATOLOGY

Dendritic Cells: A Critical Player in Cancer Therapy?

(2008) Anna Karolina Palucka et al.   JOURNAL OF IMMUNOTHERAPY

Migration of Dendritic Cell Subsets and their Precursors

(2007) Gwendalyn J. Randolph et al.   Annual Review of Immunology